原发性胃肠道滤泡性淋巴瘤的流行病学特征与预后
基于SEER数据库回顾性分析1648例原发性胃肠道滤泡性淋巴瘤(PGI-FL)与34892例结内滤泡性淋巴瘤(N-FL),PGI-FL年龄调整年均发病率为0.111/10万,中位总生存分别为207个月与165个月,5年弥漫大B细胞淋巴瘤转化率分别为2.1%与2.6%,并构建列线图预测1年、5年和10年总生存与疾病特异性生存。
要点
- PGI-FL年龄调整年均发病率为0.111/10万,过去40年发病率上升。
- PGI-FL中位总生存207个月,N-FL为165个月。
- 5年DLBCL转化率PGI-FL为2.1%,N-FL为2.6%。
核心结论
- PGI-FL发病率在过去40年上升,且预后优于N-FL、DLBCL转化率低于N-FL。
- 所构建并验证的列线图可作为个体化生存预测工具,并将患者分为三个风险组以辅助识别高危患者和选择个体化治疗。
研究设计与样本
- 回顾性分析SEER数据库中1648例PGI-FL和34892例N-FL患者。
主要发现
- PGI-FL年龄调整年均发病率为0.111/100000。
- PGI-FL中位总生存为207个月,N-FL为165个月。
- 5年DLBCL转化率PGI-FL为2.1%,N-FL为2.6%。
- 年龄、性别、分级、Ann Arbor分期、原发部位和放疗是独立预后因素(p < 0.05)。
- 按列线图评分将患者分为三个风险组。
关键数值与推荐
- 构建列线图预测1年、5年和10年总生存与疾病特异性生存,ROC曲线和校准图显示列线图性能稳健准确。
临床怎么用
- 列线图可作为个体化工具预测生存,三个风险分组有助于临床医生识别高危患者并选择最佳个体化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary gastrointestinal follicular lymphoma (PGI-FL) is a rare extra-nodal lymphoma. Its epidemiology and prognosis remain unclear. We performed a retrospective analysis of eligible patients with 1648 PGI-FL and 34 892 nodal FL (N-FL) in the Surveillance, Epidemiology and End Results (SEER) database. The age-adjusted average annual incidence of PGI-FL was 0.111/100000. The median overall survival (OS) for PGI-FL and N-FL patients was 207 and 165 months respectively. The 5-year diffuse large B-cell lymphoma (DLBCL) transformation rates were 2.1% and 2.6% respectively. Age, sex, grade, Ann Arbor stage, primary site and radiation were independent prognostic factors (p < 0.05). Nomograms were constructed to predict 1-, 5- and 10-year OS and disease-specific survival (DSS). The receiver operating characteristic curves and calibration plots showed the established nomograms had robust and accurate performance. Patients were classified into three risk groups according to nomogram score. In conclusion, the incidence of PGI-FL has increased over the past 40 years, and PGI-FL has a better prognosis and a lower DLBCL transformation rate than N-FL. The nomograms were developed and validated as an individualized tool to predict survival. Patients were divided into three risk groups to assist clinicians in identifying high-risk patients and choosing the optimal individualized treatments.
引用
- Li X, Gao F, Meng X, et al. Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma. Br J Haematol. 2024. PMID: 38447995. doi:10.1111/bjh.19393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。